Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Short Interest Up 156.3% in May
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) saw a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 536,900 shares, an increase of 156.3% from the May 15th total of 209,500 shares. Currently, 8.7% of the shares of the stock are sold short. […]
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) saw a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 536,900 shares, an increase of 156.3% from the May 15th total of 209,500 shares. Currently, 8.7% of the shares of the stock are sold short. […]
